Maternal morbidity and mortality in 442 pregancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome).
Society of Perinatal Obstetricians. Annual meeting. San Francisco CA USA, 1993/02/08.
Our purpose was to describe the incidence and effects of serious obstetric complications on maternal outcome in pregnancies complicated by HELLP syndrome.
A prospective cohort study was performed on 442 pregnancies with HELLP syndrome managed at this center from August 1977 through July 1992.
Of 437 women who had 442 pregnancies with HELLP syndrome ; 309 (70%) of the cases occurred ante partum and 133 (30%) post partum ; 149 (11%) developed at<27 weeks and 80 (18%) at term.
Maternal mortality was 1.1% (five patients)
Serious maternal morbidity included disseminated intravascular coagulation (21%), abruptio placentae (16%), acute renal failure (7.7%), pulmonary edema (6%), subcapsular liver hematoma (0.9%), and retinal detachment (0.9%).
Mots-clés Pascal : Prééclampsie, Etude cohorte, Morbidité, Mortalité, Homme, Mère, Gestation pathologie, Toxémie gravidique, HELLP syndrome
Mots-clés Pascal anglais : Preeclampsia, Cohort study, Morbidity, Mortality, Human, Mother, Pregnancy disorders, Pregnancy toxemia, HELLP syndrome
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0662314
Code Inist : 002B20F02. Création : 09/06/1995.